(Q44265040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

QTc-prolonging drugs and hospitalizations for cardiac arrhythmias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

Hubert G M Leufkens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

59-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505572%20AND%20SRC:MED&resulttype=core&format=json

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Cisapride and fatal arrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

QT prolongation and Torsades de Pointes associated with clarithromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Quinolone-induced QT interval prolongation: a not-so-unexpected class effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Sulfonylureas blockade of neural and cardiac HERG channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Polymorphic ventricular tachycardia (Torsade de Pointes) associated with the use of probucol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Laxative-induced hypokalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Interaction between corticosteroid and beta-agonist drugs. Biochemical and cardiovascular effects in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Increased QT dispersion in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3

Baseline rates of disease may account for some arrhythmia risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902998-3